Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McGill University

$28,250.00

Identification and characterization of proteins interacting with CD45

FY 2008-09

Summary
CD45, a member of the protein tyrosine phosphatase family, is critically involved in the activation of hematopoietic cells. CD45 was originally identified as a positive regulator in the immune system, but recent research revealed that CD45 as a JAK phosphatase also could negatively regulates cytokine receptor-mediated signaling in hematopoietic cells. However, the precise mechanism by which CD45 can positively and /or negatively regulate these cellular signals remains elusive. Previously, we identified several proteins interacting with CD45, such as adaptor proteins SKAP55, DOK-1, DOK-2 and Fyb, and selectively characterized the function of SKAP55 in T-cell receptor (TCR) signaling. We found that CD45 does not directly bind to kinase Fyn, a major putative CD45 substrate previously identified. Instead, it transiently recruits SKAP55 to access the kinase for dephosphorylation. Here we propose to investigate the functions of the other three adaptor proteins, DOK-1, DOK-2 and Fyb in the CD45-regulated signal pathways. We will use both biochemical and genetics tools to identify the tyrosine residues of these adaptors responsible for modulating CD45 activity. For DOK-1 and DOK-2, research will focus on whether these adaptors can play a negative role in the JAK-STAT pathway via interaction with CD45 in response to IL-3 or IFN-a stimulation. For Fyb, we are interested in investigating whether the interaction of Fyb with CD45 is necessary for integrin-dependent T cell adhesion and intact T cell actin structure following TCR activation. Functional elucidation of these adaptor proteins in the CD45-regulated immune responses will lead to the development of novel tools, such as RNA interference (RNAi), to modulate CD45 function, thus combating the various CD45-related diseases.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
183691-2006
Name nom
Shen, ShiHsiang
Department département
Medicine, Faculty of
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2006
Award amount
28250
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
3
Nb partie
5
Application title
Identification and characterization of proteins interacting with CD45
Keyword
NA
Application summary
CD45, a member of the protein tyrosine phosphatase family, is critically involved in the activation of hematopoietic cells. CD45 was originally identified as a positive regulator in the immune system, but recent research revealed that CD45 as a JAK phosphatase also could negatively regulates cytokine receptor-mediated signaling in hematopoietic cells. However, the precise mechanism by which CD45 can positively and /or negatively regulate these cellular signals remains elusive. Previously, we identified several proteins interacting with CD45, such as adaptor proteins SKAP55, DOK-1, DOK-2 and Fyb, and selectively characterized the function of SKAP55 in T-cell receptor (TCR) signaling. We found that CD45 does not directly bind to kinase Fyn, a major putative CD45 substrate previously identified. Instead, it transiently recruits SKAP55 to access the kinase for dephosphorylation. Here we propose to investigate the functions of the other three adaptor proteins, DOK-1, DOK-2 and Fyb in the CD45-regulated signal pathways. We will use both biochemical and genetics tools to identify the tyrosine residues of these adaptors responsible for modulating CD45 activity. For DOK-1 and DOK-2, research will focus on whether these adaptors can play a negative role in the JAK-STAT pathway via interaction with CD45 in response to IL-3 or IFN-a stimulation. For Fyb, we are interested in investigating whether the interaction of Fyb with CD45 is necessary for integrin-dependent T cell adhesion and intact T cell actin structure following TCR activation. Functional elucidation of these adaptor proteins in the CD45-regulated immune responses will lead to the development of novel tools, such as RNA interference (RNAi), to modulate CD45 function, thus combating the various CD45-related diseases.